Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Consolidated Net Profit

    Back to Income Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹61 Cr₹58 Cr₹43 Cr₹38 Cr₹16 Cr

What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?

The latest Consolidated Net Profit ratio of WINDLAS BIOTECH is ₹61 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹61 Cr
Mar2024₹58 Cr
Mar2023₹43 Cr
Mar2022₹38 Cr
Mar2021₹16 Cr

How is Consolidated Net Profit of WINDLAS BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹61 Cr
4.82
Mar2024 ₹58 Cr
36.51
Mar2023 ₹43 Cr
11.91
Mar2022 ₹38 Cr
140.58
Mar2021 ₹16 Cr -

Compare Consolidated Net Profit of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,639.8 Cr -0.6% -3.5% -30.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.6%

-3.5%

-30.8%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses